View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
24 June, 2021updated 29 Oct 2021 11:13

Sanofi invests $425m to expand flu vaccine production in Pennsylvania

Sanofi Pasteur, a vaccine business unit of France-based Sanofi, has received approval for an influenza production plant in Swiftwater, Pennsylvania.

By Cara Lyttle

Sanofi Pasteur, a vaccine business of Sanofi, is to open an additional influenza production plant in Swiftwater, Pennsylvania. The US FDA Centre of Biologics Evaluation and Research has granted approval for additional manufacturing at the newly completed $425m plant. The investment will create up to 200 manufacturing jobs and will initially commercialise products for the US market, with plans to expand to additional countries.

Elaine O’Hara, head of North America commercial operations for Sanofi Pasteur, said: “We are experiencing fast-growing demand for our vaccine in the US and globally, given the ten years of data demonstrating protection from flu and its related complications.”

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Data, analysis and deep insights on foreign direct investment delivered to you
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Investment Monitor